426 related articles for article (PubMed ID: 1364116)
1. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
Edgington TS; Mackman N; Fan ST; Ruf W
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
[TBL] [Abstract][Full Text] [Related]
2. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
3. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
Dickinson CD; Shobe J; Ruf W
J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
[TBL] [Abstract][Full Text] [Related]
4. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
5. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
Edgington TS; Dickinson CD; Ruf W
Thromb Haemost; 1997 Jul; 78(1):401-5. PubMed ID: 9198187
[TBL] [Abstract][Full Text] [Related]
6. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes.
Ternisien C; Ollivier V; Khechai F; Ramani M; Hakim J; de Prost D
Thromb Haemost; 1995 Mar; 73(3):413-20. PubMed ID: 7545319
[TBL] [Abstract][Full Text] [Related]
8. Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
Hirata Y; Masuda Y; Kakutani H; Higuchi T; Takada K; Ito A; Nakagawa Y; Ishii H
Biochem Pharmacol; 2008 Apr; 75(7):1504-14. PubMed ID: 18261712
[TBL] [Abstract][Full Text] [Related]
9. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-kappa B activation.
Bierhaus A; Hemmer CJ; Mackman N; Kutob R; Ziegler R; Dietrich M; Nawroth PP
Thromb Haemost; 1995 Jan; 73(1):39-48. PubMed ID: 7740494
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
Hathcock JJ; Rusinova E; Andree H; Nemerson Y
Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
[TBL] [Abstract][Full Text] [Related]
11. Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells.
Ishibashi T; Sakamoto T; Ohkawara H; Nagata K; Sugimoto K; Sakurada S; Sugimoto N; Watanabe A; Yokoyama K; Sakamoto N; Kurabayashi M; Takuwa Y; Maruyama Y
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):681-7. PubMed ID: 12692008
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
Muth H; Kreis I; Zimmermann R; Tillmanns H; Hölschermann H
Thromb Haemost; 2005 Nov; 94(5):1028-34. PubMed ID: 16363246
[TBL] [Abstract][Full Text] [Related]
14. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
15. Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains.
Fan ST; Mackman N; Cui MZ; Edgington TS
J Immunol; 1995 Apr; 154(7):3266-74. PubMed ID: 7534794
[TBL] [Abstract][Full Text] [Related]
16. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
17. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
[TBL] [Abstract][Full Text] [Related]
18. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Zhang E; St Charles R; Tulinsky A
J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
[TBL] [Abstract][Full Text] [Related]
19. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
Almus FE; Rao LV; Rapaport SI
Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
[TBL] [Abstract][Full Text] [Related]
20. Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1.
Ishii H; Takada K; Higuchi T; Sugiyama J
Thromb Haemost; 2000 Oct; 84(4):712-21. PubMed ID: 11057875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]